Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Cash Flows

v3.24.2.u1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Jun. 30, 2023
Dec. 31, 2022
Jun. 30, 2024
Jun. 30, 2023
Sep. 30, 2023
OPERATING ACTIVITIES              
Net income (loss) $ (10,968,874) $ (8,275,981) $ (12,522,646) $ (38,708,957) $ (29,270,803) $ (85,020,577)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation and amortization         203,033 199,690  
Impairment of intangible assets 0   0   0 3,900,000  
Provision for credit losses 0   0   0 3,911,714  
Noncash change in right-of-use assets         575,661 556,475  
Noncash interest expense, net of interest paid         (69,304) 1,832,092  
Gain on sale of ENTADFI® assets (110,000)   (4,723,623)   (1,028,372) (4,723,623)  
Share-based compensation         10,417,526 13,233,699  
Deferred income taxes         227,931 (213,172)  
Change in fair value of derivative liabilities (83,000)   (1,789,000)   (102,000) (2,319,000)  
Change in fair value of equity securities 117,620   0   689,548 0  
Provision for obsolete inventory         1,266,167 195,587  
Other         (2,592) 290  
Changes in current assets and liabilities:              
Decrease (increase) in accounts receivable         2,864,445 (4,729,697)  
Decrease in inventories         488,704 845,688  
(Increase) decrease in prepaid expenses and other assets         (609,130) 7,030,293  
Decrease in accounts payable         (5,173,463) (6,059,390)  
Increase (decrease) in accrued expenses and other liabilities         2,763,598 (6,707,614)  
Decrease in operating lease liabilities         (557,188) (453,809)  
Net cash used in operating activities         (17,316,239) (78,521,354)  
INVESTING ACTIVITIES              
Cash proceeds from sale of ENTADFI® assets         110,000 6,000,000  
Capital expenditures         (95,286) (452,826)  
Net cash provided by investing activities         14,714 5,547,174  
FINANCING ACTIVITIES              
Proceeds from stock option exercises         3,280 336,610  
Payment of deferred equity financing issuance costs         0 (263,757)  
Proceeds from premium finance agreement         0 1,425,174  
Installment payments on premium finance agreement         (132,975) (897,422)  
Net cash provided by financing activities         36,826,910 8,996,641  
Net increase (decrease) in cash         19,525,385 (63,977,539)  
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD   $ 9,625,494   $ 80,190,675 9,625,494 80,190,675 $ 80,190,675
CASH AND CASH EQUIVALENTS AT END OF PERIOD $ 29,150,879   $ 16,213,136   29,150,879 16,213,136 $ 9,625,494
Supplemental disclosure of cash flow information:              
Cash paid for interest         506,907 387,748  
Schedule of non-cash investing and financing activities:              
Equity securities received for sale of ENTADFI® assets         918,372 0  
Amortization of deferred costs related to common stock purchase agreement         164,313 104,849  
Shares issued in connection with common stock purchase agreement         0 1,008,000  
Right-of-use asset recorded in exchange for lease liabilities         0 264,896  
Common Stock Purchase Agreement [Member]              
FINANCING ACTIVITIES              
Proceeds from sale of shares         1,661,490 3,426,991  
Public Offering [Member]              
FINANCING ACTIVITIES              
Proceeds from sale of shares         35,228,564 0  
Jefferies Sales Agreement [Member]              
FINANCING ACTIVITIES              
Proceeds from sale of shares         66,551 0  
Stock Purchase Agreement With Frost Gamma Investment Trust FGI [Member]              
FINANCING ACTIVITIES              
Proceeds from sale of shares         $ 0 $ 4,969,045